Kawasaki Disease Clinical Trials

10 recruiting

Kawasaki Disease Trials at a Glance

10 actively recruiting trials for kawasaki disease are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Shanghai, Sioux Falls, and Torino. Lead sponsors running kawasaki disease studies include Children's Hospital of Fudan University, Duke University, and Assistance Publique - Hôpitaux de Paris.

Browse kawasaki disease trials by phase

Treatments under study

About Kawasaki Disease Clinical Trials

Looking for clinical trials for Kawasaki Disease? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Kawasaki Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Kawasaki Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Not Applicable

Kawasaki MATCH Trial

Kawasaki Disease
University of California, San Diego200 enrolled1 locationNCT07291245
Recruiting

European and North Indian Cohort of KaWasaki dIsease

Kawasaki Disease
Meyer Children's Hospital IRCCS103 enrolled27 locationsNCT06305611
Recruiting
Phase 4

Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease

Kawasaki DiseasePilot StudyRivaroxaban+1 more
Children's Hospital of Fudan University10 enrolled1 locationNCT06978439
Recruiting

Cardiovascular Risk in Children With Chronic Conditions Study

Obesity and OverweightLymphomaLeukemia+13 more
Semmelweis University300 enrolled3 locationsNCT07086989
Recruiting
Phase 4

Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease

Kawasaki DiseaseCoronary Artery Aneurysm
Children's Hospital of Fudan University100 enrolled1 locationNCT05643651
Recruiting

Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years

Kawasaki DiseaseRivaroxabanCoronary Artery Aneurysm+2 more
Children's Hospital of Fudan University60 enrolled1 locationNCT06993636
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+188 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting
Not Applicable

Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)

Kawasaki DiseaseSARS CoV-2Retrovirus Infection
IRCCS Azienda Ospedaliero-Universitaria di Bologna120 enrolled5 locationsNCT06775457
Recruiting
Phase 3

A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment

Kawasaki Disease
Assistance Publique - Hôpitaux de Paris84 enrolled1 locationNCT04656184